4//SEC Filing
CATABASIS PHARMACEUTICALS INC 4
Accession 0001104659-15-049014
$ATXSCIK 0001454789operating
Filed
Jun 29, 8:00 PM ET
Accepted
Jun 30, 6:46 PM ET
Size
7.1 KB
Accession
0001104659-15-049014
Insider Transaction Report
Form 4
Modi Rick
Chief Business Officer
Transactions
- Conversion
Common Stock
2015-06-30+4,094→ 4,094 total - Conversion
Series B Preferred Stock
2015-06-30−52,614→ 0 total→ Common Stock (4,094 underlying)
Footnotes (1)
- [F1]The Series B Preferred Stock converted into Common Stock on a 1-for-12.85 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.
Documents
Issuer
CATABASIS PHARMACEUTICALS INC
CIK 0001454789
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001454789
Filing Metadata
- Form type
- 4
- Filed
- Jun 29, 8:00 PM ET
- Accepted
- Jun 30, 6:46 PM ET
- Size
- 7.1 KB